Validation of Arabic Patient-Reported Outcome Tools for Adults Receiving Radiotherapy for Head and Neck Cancer

What this Trial Is About

Researchers are evaluating Arabic patient-reported outcome measure PROM tools for people with head and neck cancer undergoing radiotherapy. These tools have not been cross-culturally validated in Arabic-speaking patients, which limits their clinical use. The study aims to validate these PROM instruments and explore the prevalence and severity of patient concerns related to their demographics and clinical characteristics. This observational study involves Arabic-speaking adults aged 18 and older who are planned to receive, currently receiving, or have already received radiotherapy for head and neck cancer. Participants will complete six different survey tools before, during, and after radiotherapy to assess symptoms such as dry mouth, oral mucositis, fatigue, and other concerns. Participants will be asked to complete questionnaires at multiple time points over 24 months. Researchers will collect and analyze patient-reported data using tools like the Summated Xerostomia Inventory, Patient-Reported Oral Mucositis Symptom scale, and others. The study will help clinicians better understand patient experiences and outcomes during and after radiotherapy.

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.